Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D William Cameron

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Journal of Clinical Pharmacology|July 1, 2006
Time-dependent interaction between lopinavir/ritonavir and fexofenadineRolf P G van Heeswijk, Marc Bourbeau, Pearl Campbell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 5, 2010
Connection domain mutations in treatment-experienced patients in the OPTIMA trialBirgitt Dau, Dieter Ayers, Joel Singer, et al.
Frontiers in Immunology|March 6, 2024
Comparative analysis of human gut- and blood-derived mononuclear cells: contrasts in function and phenotypeStephanie C Burke Schinkel, Priscila O Barros, Tamara Berthoud, et al.
Clinical Transplantation|June 5, 2019
Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: A systematic review and meta-analysis - Part II: Non-kidney transplantSamuel Bourassa-Blanchette, Vishesh Patel, Greg A Knoll, et al.
Journal of Minimally Invasive Gynecology|December 4, 2018
Type of Pelvic Disease as a Risk Factor for Surgical Site Infectionin Women Undergoing HysterectomyInnie Chen, Abdul Jamil Choudhry, David Schramm, et al.
Pilot and Feasibility Studies|August 18, 2018
Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbationsJuthaporn Cowan, Sunita Mulpuru, Shawn Aaron, et al.
Antiviral Research|September 22, 2018
Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimensSmriti Kala, Birgit Watson, Jeremy Guijun Zhang, et al.
Plos One|November 12, 2014
The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal communityGonzalo G Alvarez, Deborah D Van Dyk, Naomi Davies, et al.
AIDS (London, England)|September 2, 2005
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adultsCurtis L Cooper, Heather L Davis, Jonathan B Angel, et al.
Assessment|November 8, 2007
Development and validation of the HIV Medication Readiness ScaleLouise Balfour, Giorgio A Tasca, John Kowal, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Pharmacology|July 1, 2006
Time-dependent interaction between lopinavir/ritonavir and fexofenadineRolf P G van Heeswijk, Marc Bourbeau, Pearl Campbell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 5, 2010
Connection domain mutations in treatment-experienced patients in the OPTIMA trialBirgitt Dau, Dieter Ayers, Joel Singer, et al.
Frontiers in Immunology|March 6, 2024
Comparative analysis of human gut- and blood-derived mononuclear cells: contrasts in function and phenotypeStephanie C Burke Schinkel, Priscila O Barros, Tamara Berthoud, et al.
Clinical Transplantation|June 5, 2019
Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: A systematic review and meta-analysis - Part II: Non-kidney transplantSamuel Bourassa-Blanchette, Vishesh Patel, Greg A Knoll, et al.
Journal of Minimally Invasive Gynecology|December 4, 2018
Type of Pelvic Disease as a Risk Factor for Surgical Site Infectionin Women Undergoing HysterectomyInnie Chen, Abdul Jamil Choudhry, David Schramm, et al.
Pilot and Feasibility Studies|August 18, 2018
Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbationsJuthaporn Cowan, Sunita Mulpuru, Shawn Aaron, et al.
Antiviral Research|September 22, 2018
Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimensSmriti Kala, Birgit Watson, Jeremy Guijun Zhang, et al.
Plos One|November 12, 2014
The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal communityGonzalo G Alvarez, Deborah D Van Dyk, Naomi Davies, et al.
AIDS (London, England)|September 2, 2005
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adultsCurtis L Cooper, Heather L Davis, Jonathan B Angel, et al.
Assessment|November 8, 2007
Development and validation of the HIV Medication Readiness ScaleLouise Balfour, Giorgio A Tasca, John Kowal, et al.
Pageof 10